Julia Diersing
University of Texas MD Anderson Cancer Center
4 Papers
Julia Diersing is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study
Xiao Zhao,Jennifer Wang,Ramona Dadu,Naifa L. Busaidy,Kim O. Learned,N. Chasen,Thinh Vu,Anastasios Maniakas,Arturo A. Eguia,Julia Diersing,Neil D. Gross,Ryan P. Goepfert,Stephen Y. Lai,Marie Claude Hofmann,Renata Ferrarotto,Charles Lu,G. Brandon Gunn,Michael T. Spiotto,Vivek Subbiah,Michelle D. Williams,Maria E. Cabanillas,Mark Zafereo +21 more
TL;DR: In this article , the authors describe the oncologic outcomes of patients with BRAFV600E-mutated anaplastic thyroid cancer (ATC) who had neoadjuvant BRAF-directed therapy with subsequent surgery.
52
Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.
Kevin J. Contrera,Maria D. Gule-Monroe,Mimi I. Hu,Maria E. Cabanillas,Naifa L. Busaidy,Ramona Dadu,Steven G. Waguespack,Jennifer Wang,Anastasios Maniakas,Stephen Y. Lai,Julia Diersing,Michael Kwon,Elizabeth G. Grubbs,Vivek Subbiah,Michelle A. Williams,Mark Zafereo +15 more
TL;DR: In this paper , the authors proposed a method to solve the problem of NN.NA, which they called N.NA-NOMA-NOCA-NA.
27
1649P A proof-of-concept study for detecting ctDNA in rare thyroid cancers
D. Vodopivec Kuri,Y. Chen,Maria E. Cabanillas,Min Hu,Naifa L. Busaidy,Ramona Dadu,Griffin Budde,M. Malhotra,Julia Diersing,Mark Zafereo +9 more
TL;DR: Signatera as discussed by the authors is a personalized commercial assay that detects circulating tumor DNA (ctDNA) and has shown molecular residual disease (MRD) in colorectal and urothelial cancer.
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
Anderson Head,Anastasios Maniakas,Yelda Jozaghi,Mark Zafereo,Erich M. Sturgis,Shirley Y. Su,Ann M. Gillenwater,Paul W. Gidley,Carol M. Lewis,Eduardo M. Diaz,Ryan P. Goepfert,Michael E. Kupferman,Neil D. Gross,Amy C. Hessel,Kristen B. Pytynia,Marc-Elie Nader,Jennifer Wang,Miriam N. Lango,Kimberley L. Kiong,Theresa Guo,Xiao Zhao,Christopher M. K. L. Yao,Eric N. Appelbaum,Jennifer Alpard,Jose A Garcia,Shawn Terry,Jill E. Flynn,Sarah Bauer,Danielle M. Fournier,Courtlyn G Burgess,Cayla Wideman,Matthew Johnston,Chenxi You,Rolando de Luna,Liza M. Joseph,Julia Diersing,Kaitlin Prescott,Katherine Heiberger,Lilian Mugartegui,Jessica Rodriguez,Sara Zendehdel,Justin Sellers,Rebekah A Friddell,Ajay Thomas,Sonam J Khanjae,Katherine B Schwarzlose,Mark S. Chambers,Theresa M. Hofstede,Richard C. Cardoso,Ruth Aponte Wesson,Alex Won,Adegbenga O. Otun,Dan S. Gombos,Nagham Al-Zubidi,Katherine A. Hutcheson,G. Brandon Gunn,David I. Rosenthal,Maura L. Gillison,Renata Ferrarotto,Randal S. Weber,Ehab Y. Hanna,Jeffrey N. Myers,Stephen Y. Lai +62 more
TL;DR: Practices in surgical oncology had to change in response to resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of health care personnel.